CASE REPORT
Resolution of bronchiectasis in 3 children. Case series description
 
More details
Hide details
1
National Tuberculosis and Lung Diseases Institute, Department of Pneumonology and Cystic Fibrosis, Rabka-Zdrój, Poland
 
 
Submission date: 2023-05-04
 
 
Final revision date: 2023-07-07
 
 
Acceptance date: 2023-07-10
 
 
Publication date: 2024-03-05
 
 
Corresponding author
Katarzyna Surówka
Katarzyna Surówka, National Tuberculosis and Lung Diseases Institute, Department of Pneumonology and Cystic Fibrosis, 3B Prof. Rudnika St., Rabka-Zdrój, Poland
 
 
Pediatr Pol 2024;99(1):71-76
 
KEYWORDS
TOPICS
ABSTRACT
Bronchiectasis is a chronic disease syndrome manifested by a productive cough, subsequent to structural changes in the bronchial walls resulting from bacterial infection and leading to the retention of secretions. In some patients, the cause of bronchiectasis is chronic diseases, such as cystic fibrosis, ciliary dyskinesia, α1-antitrypsin deficiency, or congenital immune disorders. However, there are cases of bronchiectasis without underlying chronic disease, e.g. as a consequence of severe lower respiratory tract infection (bacterial or viral) or local airway obstruction, caused by foreign body aspiration or external pressure. Currently, it is believed that in some patients bronchial deformations may be reversible with a sufficiently quick diagnosis and implementation of treatment. The paper presents the cases of 3 children in whom the resolution of dilated lesions was confirmed by computed tomography.
REFERENCES (27)
1.
Nicotra MB. Bronchiectasis. Semin Respir Infect 1994; 9: 31-40.
 
2.
Gallucci M, di Palmo E, Bertelli L, et al. A pediatric disease to keep in mind: diagnostic tools and management of bronchiectasis in pediatric age. Ital J Pediatr 2017; 43: 117.
 
3.
Kolbe J, Wells AU. Bronchiectasis: a neglected cause of respiratory morbidity and mortality. Respirology 1996; 1: 221-225.
 
4.
Coleman LT, Kramer SS, Markowitz RI, et al. Bronchiectasis in children. J Thorac Imaging 1995; 10: 268-279.
 
5.
Eastham KM, Fall AJ, Mitchell L, et al. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax 2004; 59: 324-327.
 
6.
Chang AB, Fortescue R, Grimwood KI, et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. Eur Respir J 2021; 58: 2002990.
 
7.
Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet 2018; 392: 866-879.
 
8.
Krenke K. Rozstrzenie oskrzeli. In: Kulus M, Krenke K (eds). Pulmonologia dziecięca, PZWL, Warszawa 2018, 333-335.
 
9.
Chang AB, Marchant JM. Protracted bacterial bronchitis is a precursor for bronchiectasis in children: myth or maxim? Breathe 2019; 15: 167-170.
 
10.
Cole P. Host-microbe relationships in chronic respiratory infection. Respiration 1989; 55: 5-8.
 
11.
Tiddens H, Meerburg J, van der Eerden M, et al. The radiological diagnosis of bronchiectasis: what’s in a name? Eur Resp Rev 2020; 29: 190120.
 
12.
Sandora T, Harper M. Pneumonia in hospitalized children. Pediatr Clin N Am 2005; 52: 1059-1081.
 
13.
Mansour Y, Beck R, Danino J, et al. Resolution of severe bronchiectasis after removal of long-standing retained foreign body. Pediatr Pulmonol 1998; 25: 130-132.
 
14.
Sirmali M, Türüt H, Kisacik E, et al. The relationship between time of admittance and complications in paediatric tracheobronchial foreign body aspiration. Acta Chir Belg 2005; 105: 631-634.
 
15.
Baris S, Ercan H, Cagan HH, et al. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency. J Investig Allergol Clin Immunol 2011; 21: 514-521.
 
16.
McCallum GB, Binks MJ. The epidemiology of chronic suppurative lung disease and bronchiectasis in children and adolescents. Front Pediatr 2017; 5: 27.
 
17.
Wilkinson M, Sugumar K, Milan SJ. Mucolytics for bronchiectasis. Cochrane Database Syst Rev 2014; 2014: CD001289.
 
18.
Anuradha KWDA, Gunathilaka PKG, Wickramasinghe VP. Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: a randomized control trial. Pediatr Pulmonol 2021; 56: 509-515.
 
19.
Shoemark A, Shteinberg M, De Soyaz A, et al. Characterization of eosinophilic bronchiectasis, a European Multicohort Study. Am J Resp Crit Care Med 2022; 205: 894-902.
 
20.
Singh D, Brightling C. Bronchiectasis, the latest eosinophilic airway disease: what about the microbiome? Am J Resp Crit Care Med 2022; 205: 860-862.
 
21.
Tsikrikaa S, Dimakoub K, Papaioannouc A, et al. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis. Cytokine 2017; 99: 281-286.
 
22.
Dente F, Bilotta M, Bartoli M, et al. Neutrophilic bronchial inflammation correlates with clinical and functional findings in patients with noncystic fibrosis bronchiectasis. Mediators Inflamm 2015; 2015: 642503.
 
23.
Aliberti S, Chalmers J. Get together to increase awareness in bronchiectasis: a report of the 2nd World Bronchiectasis Conference. Multidiscip Respir Med 2018; 13: 28.
 
24.
Kapur N, Petsky H, Bell S, et al. Inhaled corticosteroids for bronchiectasis. Cochrane Database Syst Rev 2018; 2018: CD000996.
 
25.
Hnin K, Nguyen C, Evans D, et al. Prolonged antibiotics for non‐cystic fibrosis bronchiectasis in children and adults. Cochrane Database Syst Rev 2015; 2015: CD001392.
 
26.
Haidopoulou K, Calder A, Jones A, et al. Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function. Pediatr Pulmonol 2009; 44: 669-675.
 
27.
Crowley S, Matthews I. Resolution of extensive severe bronchiectasis in an infant. Pediatr Pulmonol 2010; 45: 717-720.
 
Journals System - logo
Scroll to top